It means a subcutaneous injection delivers a very short exposure window before the peptide is fragmented
10.1042/bj1030483 542 SmithL
GLP-1 OzempicWegovyNAION 2025 6 EMA semaglutide Ozempic Wegovy Rybelsus NAION 2026 2 MHRA NAION NAION Non-Arteritic Anterior Ischemic Optic Neuropathy NAION NAION 50 NAION MHRA Drug Safety Update, 2026 NAION semaglutide Semaglutide GLP-1 GLP-1 receptor agonist GLP-1 dulaglutideliraglutidetirzepatide EMA 2025 6 NAION semaglutide very rare 10,000 1 /Hathaway et al., 2024 JAMA Ophthalmology 2017-2023 semaglutide 36 NAION 8.9% vs
ATB 0,+ ( SLC6A14 ) is a Na + and Cl -dependent amino acid transporter widely distributed in lung, trachea, salivary gland, breast, stomach, eye, hippocampus, intestine, bloodbrain barrier and other tissues
The medication will be sold under the brand name Litfulo, and is manufactured by Pfizer